AIP
TYRA icon

Ameritas Investment Partners’s Tyra Biosciences TYRA Stock Holding History

Ameritas Investment Partners’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.3K Hold
1,991
– – ﹤0.01% 1844
2025
Q4 		$52.3K Hold
1,991
– – ﹤0.01% 2087
2025
Q3 		$27.9K Hold
1,991
– – ﹤0.01% 2521
2025
Q2 		$19.1K Hold
1,991
– – ﹤0.01% 2684
2025
Q1 		$18.5K Hold
1,991
– – ﹤0.01% 2589
2024
Q4 		$27.7K Hold
1,991
– – ﹤0.01% 2493
2024
Q3 		$46.8K Hold
1,991
– – ﹤0.01% 2230
2024
Q2 		$31.8K Buy
1,991
+1,051
+112% +$18.1K ﹤0.01% 2388
2024
Q1 		$15.4K Hold
940
– – ﹤0.01% 2669
2023
Q4 		$13K Hold
940
– – ﹤0.01% 2757
2023
Q3 		$12.9K Hold
940
– – ﹤0.01% 2721
2023
Q2 		$16K Hold
940
– – ﹤0.01% 2677
2023
Q1 		$15.1K Hold
940
– – ﹤0.01% 2562
2022
Q4 		$7.4K Hold
940
– – ﹤0.01% 2867
2022
Q3 		$8K Hold
940
– – ﹤0.01% 2865
2022
Q2 		$6K Hold
940
– – ﹤0.01% 2944
2022
Q1 		$10K Hold
940
– – ﹤0.01% 2802
2021
Q4 		$13K Buy
+940
New +$18.7K ﹤0.01% 2825

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Ameritas Investment Partners's TYRA Position: Q1 2026 in Review

Ameritas Investment Partners held its Tyra Biosciences (TYRA) position steady in Q1 2026 at 1,991 shares worth $76.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1844.

Ameritas Investment Partners first reported a position in TYRA in Q4 2021 and has held it in 18 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Ameritas Investment Partners held 1,991 shares of Tyra Biosciences worth $76.3K as of Q1 2026.
  • Ameritas Investment Partners left its Tyra Biosciences share count unchanged in Q1 2026.
  • Tyra Biosciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1844 holding.
  • Ameritas Investment Partners first reported a position in Tyra Biosciences in Q4 2021 and has held it in 18 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.